The Enterprise Value as of September 2024 (TTM) for ContraFect Corporation (CFRX) is -1135867.00

According to ContraFect Corporation’s latest financial reports and current stock price. The company's current Enterprise Value is -1135867.00. This represents a change of -55.26% compared to the average of -2538630.02 of the last 4 quarters.

ContraFect Corporation (CFRX) Historical Enterprise Value (quarterly & annually)

How has CFRX Enterprise Value performed in the past?

The mean historical Enterprise Value of ContraFect Corporation over the last ten years is 59.49M. The current -1135867.00 Enterprise Value has changed -290.93% with respect to the historical average. Over the past ten years (40 quarters), CFRX's Enterprise Value was at its highest in in the June 2018 quarter at 158.22M. The Enterprise Value was at its lowest in in the March 2023 quarter at -6150878.92.

ContraFect Corporation (CFRX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of ContraFect Corporation Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

ContraFect Corporation (CFRX) Average Enterprise Value

How has CFRX Enterprise Value performed in the past?

The current Enterprise Value of ContraFect Corporation (CFRX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

ContraFect Corporation (CFRX) Enterprise Value vs. Peers

How is CFRX’s Enterprise Value compared to its peers?

ContraFect Corporation’s Enterprise Value is less than Palisade Bio, Inc. (0), greater than Allarity Therapeutics, Inc. (-6131584.00), greater than CNS Pharmaceuticals, Inc. (-13147369.00), less than Windtree Therapeutics, Inc. (3.43M), less than Quoin Pharmaceuticals, Ltd. (3.94M), less than Revelation Biosciences, Inc. (-397055.00), greater than Virax Biolabs Group Limited (-10569356.00), less than Unicycive Therapeutics, Inc. (9.05M), less than NeuroBo Pharmaceuticals, Inc. (40.55M), less than Hillstream BioPharma, Inc. (2.76M), less than First Wave BioPharma, Inc. (1.48M), less than Dermata Therapeutics, Inc. (9.55M), greater than Panbela Therapeutics, Inc. (-2170380.00), less than null (5.76M),

Build a custom stock screener for ContraFect Corporation (CFRX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ContraFect Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ContraFect Corporation (CFRX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ContraFect Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.